Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide — Stella

Recruiting

Back to Traumatic Brain Injury trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Key details

Phase

Post-approval study

Sponsor

Wake Forest University Health Sciences

Enrollment target

~600 participants

Started

April 2025

Primary completion

April 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov